Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/1598
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFitzgerald, Rhysen_US
dc.contributor.authorPryor, Daviden_US
dc.contributor.authorAland, Trenten_US
dc.contributor.authorAnderson, Leeen_US
dc.contributor.authorKnesl, Marcelen_US
dc.contributor.authorFong, Andrewen_US
dc.contributor.authorLunn, Dominicen_US
dc.contributor.authorOar, Andrewen_US
dc.contributor.authorJackson, Jamesen_US
dc.contributor.authorFoote, Matthewen_US
dc.date.accessioned2021-09-27T01:21:53Z-
dc.date.available2021-09-27T01:21:53Z-
dc.date.issued2020-06-
dc.identifier.citationFitzgerald R, Pryor D, Aland T, Anderson L, Knesl M, Fong A, Lunn D, Oar A, Jackson J, Foote M. Quality and access - Early experience of implementing a virtual stereotactic chart round across a national network. J Med Imaging Radiat Oncol. 2020 Jun;64(3):422-426. doi: 10.1111/1754-9485.13031en_US
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/1598-
dc.description.abstractStereotactic radiation therapy is a highly specialised technique which requires careful and structured implementation. As part of a national stereotactic programme implementation, protocols were developed and a national stereotactic chart round was formed, which strongly recommended attendance and presentation of all cases before treatment. Herein, we describe our experiences launching a national chart round and its importance in a stereotactic programme. Stereotactic chart rounds were held via videoconference between July 2018 and July 2019. Data collected included attendances, patient-related information including, diagnosis, clinical background, treatment intent, prescribed dose and fractionation and technical approach. Consensus recommendations regarding changes to treatment approaches were also recorded. For the 12 months recorded, there were 1126 attendances, from 144 individual attendees, across 21 locations. In total, 285 cases (237 new cases, and 48 re-presentations) were presented by 27 radiation oncologists (ROs) from 13 different locations. From the cases presented, 65 changes were recommended from 53 patients (22.3%), including 27 (11.4%) changes to contours, 18 (7.6%) changes to dose prescription/fractionation, 9 (3.8%) changes to plan dosimetry, 1 (0.4%) changes to treatment technique and 10 (4.2%) recommendations for which stereotactic radiation therapy was not advised. A significant inverse relationship was found between frequency of recommended changes and the individual RO's stereotactic case load (P < 0.002). The implementation of a national stereotactic chart held via videoconference has ensured national protocol compliance across the network of locations. Furthermore, the chart rounds have allowed the entire multidisciplinary team to be provided with mentorship and guidance. Increasing number of cases presented was associated with lower rates of recommended changes highlighting the impact of experience and the need for continued mentorship.en_US
dc.language.isoenen_US
dc.publisherWiley-Blackwell Publishing Asiaen_US
dc.relation.ispartofJournal of medical imaging and radiation oncologyen_US
dc.subjectClinical Protocolsen_US
dc.subjectConsensusen_US
dc.subjectPeer Review, Health Careen_US
dc.subjectQuality Assurance, Health Careen_US
dc.subjectRadiosurgeryen_US
dc.subjectChart rounden_US
dc.subjectDosimetryen_US
dc.subjectStereotacticen_US
dc.titleQuality and access - Early experience of implementing a virtual stereotactic chart round across a national networken_US
dc.typeArticleen_US
dc.identifier.doi10.1111/1754-9485.13031-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Sites:Gold Coast Health Publications
Show simple item record

Page view(s)

102
checked on Nov 22, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.